Suzhou Novoprotein Hits Day Low of CNY 36.07 Amid Price Pressure

Suzhou Novoprotein Scientific Co., Ltd. experienced a significant decline today, with the stock dropping by 7.96% and reaching an intraday low of CNY 36.07. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Over the past week, Suzhou Novoprotein's stock has decreased by 5.77%, while its one-month performance shows a modest gain of 5.57%. However, the company's longer-term outlook remains concerning, with a year-to-date decline of 8.24% and a substantial drop of 20.11% over the past year. The three-year performance reflects a significant downturn of 29.33%. Financial metrics indicate challenges for the company, including a low Return on Capital Employed (ROCE) of 3.40% and a negative Return on Equity (ROE) of -3.79%. Additionally, the company has reported negative net profit for the last ten consecutive quarters, with net profit for the first nine months at CNY -28.86 million, reflecting a decline of 75.4%. The stock's high debt levels and poor sales growth further underscore the difficulties faced by Suzhou Novoprotein in the current market environment.